Drug marker Macleods Pharmaceuticals has decided to put its staff on prophylaxis treatment of hydroxychlroquine (HCQ), even as a debate rages over its efficacy in treating Covid-19 and whether it should be given to non-health workers.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gPZH7p
via IFTTT
0 comments:
Post a Comment